SCHEMBL3406095

SCHEMBL3406095

COc1cc(Nc2nc(C(C)C)cc(C(F)(F)F)n2)ccc1-c1nc(C)c[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
CRHBP P24387 1/20 0.44
CYP2C19 P33261 1/20 0.44
CRHR2 Q13324 1/20 0.44
ABCB1 P08183 1/20 0.38
ABCC1 P33527 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
IMPDH2 P12268 9/20 0.37
KCNH2 Q12809 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ULK1 O75385 1/20 0.35
ULK2 Q8IYT8 1/20 0.35
PSEN1 P49768 2/20 0.33
PSEN2 P49810 2/20 0.33
APH1B Q8WW43 2/20 0.33
NCSTN Q92542 2/20 0.33
APH1A Q96BI3 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3409749 0.91 IMPDH2 (0.42) ABCB1ABCC1ABCG2IMPDH2KCNH2
SCHEMBL3406662 0.91 NPC1 (0.40) ABCG2IMPDH2KCNH2NPC1RAB9A
SCHEMBL3411934 0.89 CDK1 (0.35) CYP3A4CYP2D6TSHRCRHBPCYP2C19
SCHEMBL3405216 0.87 IMPDH2 (0.39) ABCB1ABCC1ABCG2IMPDH2KCNH2
SCHEMBL3406106 0.83 IGF1R (0.41) PLK1
SCHEMBL3406878 0.83 SYK (0.50)
SCHEMBL3407100 0.81 MAPT (0.48) CYP3A4CYP2D6CYP2C19JAK2
SCHEMBL3410260 0.81 NPC1 (0.53) ABCG2IMPDH2KCNH2NPC1RAB9A
SCHEMBL3406812 0.81 IMPDH2 (0.39) CYP3A4CYP2D6CYP2C19IMPDH2ULK1
SCHEMBL3412371 0.80 MEN1 (0.40) IMPDH2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257541-A1 MODULATORS FOR AMYLOID BETA F. Hoffmann-La Roche AG (CH) 2010-12-08 EP disclosed
WO-2009103652-A1 MODULATORS FOR AMYLOID BETA F. HOFFMANN-LA ROCHE AG (CH) 2009-08-27 WO disclosed